logo
episode-header-image
Apr 2022
1h 23m

PsychEd Episode 43: Psychedelic-Assisted...

PSYCHED
About this episode

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers psychedelic-assisted psychotherapy with Dr Emma Hapke and Dr Daniel Rosenbaum, both of whom are psychiatrists at the University Health Network in Toronto and co-founders of UHN’s Nikean Psychedelic Psychotherapy Research Centre (in addition to being lecturers in the Department of Psychiatry at the University of Toronto).

 

The learning objectives for this episode are as follows:

 

By the end of this episode, you should be able to…

  1. Briefly describe the history of psychedelics in psychiatry
  2. List the four classes of psychedelic drugs and their mechanism of action
  3. Summarize the evidence regarding psychedelic-assisted psychotherapy for various psychiatric disorders
  4. Discuss patient selection considerations for psychedelic-assisted psychotherapy
  5. Describe the safety, tolerability and possible side effects of psychedelic-assisted psychotherapy
  6. Understand how a psychedelic-assisted psychotherapy session is practically carried out

 

Guests: Dr Emma Hapke and Dr Daniel Rosenbaum

 

Hosts: Dr Chase Thompson (PGY4), Dr Nikhita Singhal (PGY3), Jake Johnston (CC4), and Annie Yu (CC4)

 

Audio editing by: Nikhita Singhal

 

Show notes by: Nikhita Singhal

 

Interview Content:

  • Introduction - 0:00
  • Learning objectives - 02:47
  • Definitions/categories of psychedelics - 03:24
    • Classic psychedelics - 04:15
    • Empathogens (e.g. MDMA) - 07:15
    • Etymology of the term “psychedelic” - 09:30
    • Ketamine - 12:24
    • Iboga - 13:28
  • Brief history of psychedelic medicine - 17:51
  • Current evidence and ongoing trials - 27:38
    • MDMA and PTSD - 29:26
    • Psilocybin and treatment-resistant depression - 32:24
    • A word of caution - 34:29
    • End-of-life care - 38:47
  • Practical aspects of psychedelic-assisted psychotherapy sessions - 45:45
  • Safety considerations - 01:04:04
  • Future directions - 01:10:33
  • Closing comments - 01:19:07

 

Resources:

 

References:

  • Carhart-Harris R, Giribaldi B, Watts R, et al. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021;384(15):1402-1411. https://doi.org/10.1056/nejmoa2032994
  • Carhart-Harris R, Nutt D. Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology. 2017;31(9):1091-1120. https://doi.org/10.1177/0269881117725915
  • Davis AK, Barrett FS, May DG, et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2021;78(5):481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285
  • Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181-1197. dhttps://dx.doi.org/10.1177%2F0269881116675513
  • Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol. 2018;32(1):49-69. https://doi.org/10.1177/0269881117731279
  • Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacol Ther. 2019;197:83-102. https://doi.org/10.1016/j.pharmthera.2018.11.010
  • Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27(6):1025-1033. https://doi.org/10.1038/s41591-021-01336-3
  • Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018;5(6):486-497. https://doi.org/10.1016/s2215-0366(18)30135-4
  • Nicholas CR, Henriquez KM, Gassman MC, et al. High dose psilocybin is associated with positive subjective effects in healthy volunteers. J Psychopharmacol. 2018;32(7):770-778. https://doi.org/10.1177/0269881118780713
  • Reiff CM, Richman EE, Nemeroff CB, et al. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry. 2020;177(5):391-410. https://doi.org/10.1176/appi.ajp.2019.19010035
  • Rosenbaum D, Boyle AB, Rosenblum AM, Ziai S, Chasen MR, Med MP. Psychedelics for psychological and existential distress in palliative and cancer care. Curr Oncol. 2019;26(4):225-226. https://dx.doi.org/10.3747%2Fco.26.5009
  • Swift TC, Belser AB, Agin-Liebes G, et al. Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress. Journal of Humanistic Psychology. 2017;57(5):488-519. https://doi.org/10.1177/0022167817715966

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

 

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.

Up next
Jul 1
PsychEd Episode 67: Catatonia with Dr. Patricia Rosebush
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.This episode covers catatonia with Dr. Patricia Rosebush. Dr. Rosebush is a Professor in the Department of Psychiatry & Behavioural Neurosciences at McMaster University. She is the distinguished ... Show More
1h 1m
May 1
PsychEd Shorts 2: Antidepressant Counselling
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.This short episode is about counselling patients on antidepressant medications.Hosts: Matthew Cho and Angad SinghAudio editing: Angad SinghTime stamps:(02:03) Steps to antidepressant counselling( ... Show More
15m 31s
Mar 2025
PsychEd Book Club 1: Mind Fixers
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.This is our inaugural book club episode centred around the book Mind Fixers by Anne Harrington. Mind Fixers is by the Harvard historian Anne Harrington, and came out from Norton in 2022. It refra ... Show More
1h 4m
Recommended Episodes
May 2023
Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health
In this episode, my guest is Robin Carhart-Harris, PhD, distinguished professor of neurology and psychiatry at the University of California, San Francisco. He is one of leading researchers in the study of how psychedelics such as psilocybin, LSD and DMT can change the human brain ... Show More
2h 32m
Aug 2022
Psychedelic-Assisted Therapy with Dr. Albert Garcia Romeu
There’s been an explosion of interest in psychedelics over the last 10 years, and phrases like “psychedelic-assisted therapy” have gone from the relative fringes of the mental health conversation to bursting into the mainstream. Alongside a great deal of hype is a growing body of ... Show More
1h 8m
Sep 2021
Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders
This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and L ... Show More
2h 49m
Jul 2023
Dr. Robin Carhart-Harris: An Expert’s Guide to the Medicinal Potential of Psychedelics
On this week’s episode, WHOOP VP of Performance Science, Principal Scientist, Kristen Holmes is joined by Dr. Robin Carhart-Harris, a distinguished professor of neurology and psychiatry at the University of California, San Francisco. He is one of the leading researchers in the st ... Show More
55m 5s
Nov 2016
Mushrooms 101: Everything You Need To Know About The Psilocybin Psychedelics That Are Taking The Health World By Storm.
This is a special Premium audio episode. Click here to activate a Premium subscription to the BenGreenfieldFitness show and access this and over 300 additional hidden audios, videos, pdf's and more! Psychedelic drugs such as MDMA (AKA "Ecstacy") LSD and Psilocybin (AKA “magic” mu ... Show More
1h 3m
Jan 2023
Can Psychedelic Medicine Fix Our Mental Health Crisis with Rick Doblin
This episode is brought to you by Rupa Health, Cozy Earth, Beekeeper’s Naturals, and Levels. We’re in the midst of a psychedelic renaissance. Compounds that have long been considered recreational drugs by conventional standards are finally being recognized through science as powe ... Show More
1h 37m
Jun 2020
What Happens During A Psychedelic Journey: Dr. Matthew Johnson On Psychedelic Treatment Room, The State Of Psychedelic Research & Future of Psychedelic Therapy.
bengreenfieldfitness.com/psychedelics My guest on today's show, Dr. Matthew W. Johnson, Ph.D., is a professor of psychiatry and behavioral sciences at Johns Hopkins University.     He also happens to be one of the world’s most published scientists on the topic of the effects of p ... Show More
1h 22m
Jun 2020
Microdosing, Biohacking Plant Medicines, Psychedelic-Enhanced Psychotherapy & More - How "Field Trip Health" Works For Ketamine, MDMA, DMT, Psilocybin & Beyond!
bengreenfieldfitness.com/fieldtrip Field Trip Psychedelics Inc. is the world's first mental wellness company focused on psychedelics and psychedelic-enhanced psychotherapy, is beginning to open the first medical centers - first in Toronto, New York and LA - dedicated exclusively ... Show More
1h 1m
Jan 2023
What Promise Do Psychedelics Hold As Therapeutics?
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More
34m 17s